ESCRS 2024: A new EDOF IOL brings functional outcomes into the spotlight
Professor Gerd Auffarth shares patients’ and colleagues’ responses to a new IOL with a monofocal-like dysphotopsia profile
ESCRS 2024: 36-month results following femtosecond laser image-guided high precision trabeculotomy (FLigHT)
Rick Lewis, MD, speaks about a non-pharmaceutical approach to treating glaucoma with laser technology
Magnetic cell therapy for corneal endothelial dysfunction
Phase 1 multicentre study data demonstrate early signs of efficacy
Unite and conquer: Refractive surgery goes on a world tour
The ESCRS Moving Simulator initiative brings surgical training to nations in need
Filomena Ribeiro, MD, PhD, FEBO, discusses escape rooms, inclusivity initiatives and everything else ESCRS
Dr Ribeiro, President of the European Society of Cataract and Refractive Surgeons, previewed the 2024 congress
BVI announces launch of SERENITY and SERENITY Toric IOLs at ESCRS
The non-diffractive, aspheric IOLs are the second generation of BVI’s ISOPURE family
Corneal nerve regeneration following semaglutide therapy
A case report demonstrates independent effect of GLP-1 receptor agonist
The digital OR: Retina care of tomorrow
The future of the tech-forward surgical suite
Research findings illustrate role of vitamin D in preventing retinal vein occlusion
A meta-analysis indicates a "significant association" between vitamin D deficiency and increased risk of RVO
A field guide to optic disc drusen
Clinical associations, imaging strategies and establishing a differential diagnosis from pseudopapilloedema
Rayner announces launch of RayOne Galaxy spiral IOL
The IOL, designed with artificial intelligence, will launch at this year's ESCRS Congress in Barcelona, Spain
The shifting landscape of conjunctival hyperemia
European patients navigate new therapies and market change-ups
Phase 1/2 Study suggests efficacy of novel eye drop to reverse cataracts
The drop breaks up degraded protein complexes which cause lens clouding
Research indicates long-term effect of COVID-19 on corneal endothelial cell morphology
Specular microscopy showed "long-term alterations" in corneal cells
Why the future of glaucoma care is in the operating room
Smaller surgeries, in greater numbers, await new glaucoma specialists
The CHAMP clinical trial and NVK002 for controlling paediatric myopia
Determining the medication’s safety and efficacy for paediatric patients
Ranibizumab biosimilar LUBT010 (Lupin) reaches primary endpoint in global Phase 3 study
Lupin has successfully completed a clinical study of LUBT010, a ranibizumab biosimilar to Lucentis
US FDA issues approval for Sandoz aflibercept-abzv (Enzeevu)
The biosimilar is indicated to improve and maintain visual acuity for patients with neovascular age-related macular degeneration
Going for Gold: The new standard for cross-linking
Stabilising keratoconus and improving vision using ELZA-PACE customised CXL
Untangling the genetic secrets of retinoblastoma
Identifying all genetic culprits may improve diagnostics and prognoses
ASRS abroad: Retina specialists converge in Sweden
A postcard from the American Society of Retina Specialists meeting in Stockholm
LENSAR receives certification for new adaptive cataract treatment system
The ALLY Adaptive Cataract Treatment System will be the first EU ALLY commercial installation
Vision loss, cholesterol identified as risk factors associated with dementia
A list of 14 risk factors indicate dementia is not an inevitable consequence of aging
August is Children’s Eye Health and Safety Month
The nonprofit Prevent Blindness recognised the awareness month with a slate of resources
European Commission issues approval for faricimab (Vabysmo) for treatment of retinal vein occlusion
In a press release, Roche noted that up to 60% of patients were able to extend treatment intervals to 3 or 4 months
Kiora Pharmaceuticals receives Orphan Medicinal Product Designation for KIO-301
The EMA issued a designation for the small molecule photoswitch, which targets inherited retinal diseases including retinitis pigmentosa
ViaLase Laser receives CE Mark, announces first EU distribution partners
Femtosecond laser, image-guided, high-precision trabeculotomy (FLigHT) received approval for patients in Europe with primary open-angle glaucoma
ASRS 2024: Real-world treatment outcomes from a study of patients with retinal vein occlusion
Consultant ophthalmologist Christiana Dinah, BSc, MB BS, MRes, presented research findings on retinal vein occlusion in the United Kingdom
ASRS 2024: Real-world impact of vitrectomy surgery on age-related macular degeneration
Chase Ludwig, MD, speaks about the effect of vitrectomy on the progression of age-related macular degeneration
Novaliq receives positive CHMP opinion for Vevizye in treatment of dry eye disease
The positive opinion comes with the recommendation that ciclosporin 0.1% be granted marketing authorisation in the European Union